[Thymic hormone treatment of acute and chronic respiratory infections in the elderly].
Respiratory infections are particularly frequent in aged subjects and cause severe and often inauspicious complications) such as compromised cell-mediated immunity. Preliminary data suggest thymopentin treatment in a population of elderly subjects affected by relapses of bronchial disease. The effects of the therapy are adequately monitored controlling immunologic parameters.
Agostinelli
M
M
Zaia
A M
AM
Fiorentini
A
A
Stecconi
R
R
Fabris
N
N
Scalise
G
G
D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D001991:Bronchitis / Q000188:drug therapy* / Q000276:immunology; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000276:immunology; D016305:Thymopentin; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
D010446:Peptide Fragments; D013946:Thymopoietins; D013951:Thymus Hormones; D016305:Thymopentin
Il trattamento con ormoni timici delle infezioni respiratorie acute e croniche dell'anziano.